drugset / Trial / NCT05235854

Six-month Performance of Meniscal Wall Infiltration Under Ultrasound to Treat Stable Degenerative Meniscal Injuries.

NCT05235854

Phase 1 Completed 70 enrolled Nîmes University Hospital
RandomizedParallel-groupDouble-blindTreatment

Summary

The main hypothesis of the study is that in situ infiltration of the meniscal lesion would provide patients with lasting and greater relief than intra-articular infiltration. A statistically significant difference would be if the Lysholm score of the meniscal wall group at 3 months is 9.5 points higher than that of the intra-articular infiltration group. The aim is to evaluate the effectiveness of meniscal wall infiltration under ultrasound in the treatment of stable degenerative meniscal lesions versus intra-articular infiltration (Gold standard) at 3 months by Lysholm's algo-functional score.

Timeline

Start
2022-05-12
Primary completion
2026-05-04
Completion
2026-05-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Betamethasone Other / unclassified 2 mg Other

Indications